13 July 2026
Marechale Capital plc
("Marechale" or the "Company")
Grant of Options
Director/PDMR Dealing
Marechale Capital plc (AIM: MAC), an established City of London based corporate
finance advisory business, developing into a fully integrated digital merchant
bank providing corporate finance, capital markets and asset management services
underpinned by a technology solutions and distribution platform, announces that
it has granted in aggregate 8,750,000 options over ordinary shares of the
Company, at an exercise price of 4.75 pence per ordinary share, being the
closing mid-market price on 10 July 2026 (the "Share Options") to Directors, a
PDMR and an employee of the Company.
Further details of the grant of Share Options are set out in the Notification of
Dealing Form below.
Number of Share Resultant Number of As a % of Current
Options Granted Share Options Held Issued Share
Capital
Mark Warde 3,000,000 4,315,217 1.68%
-Norbury
Patrick 3,000,000 13,900,859 5.40%
Booth
-Clibborn
Patrick 1,500,000 1,500,000 0.58%
Claridge
Nick Cowan 750,000 750,000 0.29%
Others 500,000 1,450,000 0.56%
Total 8,750,000 21,916,076 8.52%
The issued share capital of the Company is 257,287,255 ordinary shares.
Following the grant of the Share Options, the Company will have 24,016,076
options over ordinary shares in issue representing approximately 9.33 per cent.
of the Company's current issued share capital.
Related Party Transactions
The grant of options to Mark Warde-Norbury, Patrick Booth-Clibborn and Patrick
Claridge constitutes a related party transaction pursuant to Rule 13 of the AIM
Rules for Companies by virtue of them being Directors of the Company (the
"Transaction"). With the exception of Mark Warde-Norbury, Patrick Booth-Clibborn
and Patrick Claridge, the Director independent of the Transaction, being Chris
Kenning, having consulted with the Company's nominated adviser, Cairn Financial
Advisers LLP, considers that the terms of the Transaction are fair and
reasonable insofar as shareholders are concerned.
This announcement contains inside information for the purposes the UK Market
Abuse Regulation.
For further information please contact:
Enquiries
Marechale Capital Tel: +44 (0)20 7628 5582
Patrick Booth-Clibborn / Mark Warde-Norbury
Cairn Financial Advisers LLP (Nominated Adviser) Tel: +44 (0)20 7213 0880
Jo Turner / Sandy Jamieson
Vigo Consulting (Financial Public Relations) Tel: +44 (0)20 7390 0230
Jeremy Garcia / Joe Quinlan
marechale@vigoconsulting.com
About Marechale Capital plc
Marechale Capital plc is one of the UK's first publicly quoted, fully integrated
digital merchant banks.
The Group bridges traditional and digital asset markets, sitting at the centre
of a rapidly growing market for tokenised assets. The Group operates across four
businesses - Marechale Capital, Stanford Capital Partners, Blubird Global, Inc,
and NJC Capital Management Limited- providing services across corporate finance,
capital markets, tokenisation and asset management. This comprehensive offering
is underpinned by ownership of the Blubird technology platform.
Marechale Capital plc is quoted on the AIM Market of the London Stock Exchange
under the ticker MAC.
For more information: https://marechalecapital.com/
Forward looking statement disclaimer
Certain statements made in this announcement are forward-looking statements.
These forward-looking statements are not historical facts but rather are based
on the Company's current expectations, estimates, and projections about its
industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,'
'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions
are intended to identify forward-looking statements. These statements are not
guarantees of future performance and are subject to known and unknown risks,
uncertainties, and other factors, some of which are beyond the Company's
control, are difficult to predict, and could cause actual results to differ
materially from those expressed or forecasted in the forward-looking statements.
The Company cautions shareholders and prospective shareholders not to place
undue reliance on these forward-looking statements, which reflect the view of
the Company only as of the date of this announcement. The forward-looking
statements made in this announcement relate only to events as of the date on
which the statements are made. The Company will not undertake any obligation to
release publicly any revisions or updates to these forward-looking statements to
reflect events, circumstances, or unanticipated events occurring after the date
of this announcement except as required by law or by any appropriate regulatory
authority.
Notification
of a
Transaction
pursuant to
Article
19(1) of
Regulation
(EU) No.
596/2014
1 Details of the person
discharging managerial
responsibilities/person
closely associated
a. Name
i. Mark Warde
-Norbury
ii. Patrick Booth
-Clibborn
iii. Patrick
Claridge
iv. Nick Cowan
2 Reason for notification
a. Position/Status
i. Executive
Chairman
ii. Chief Executive
Officer
iii. Executive
Director
iv. PDMR
b. Initial Initial Notification
notification/Amendment
3 Details of the issuer,
emission allowance market
participant, auction
platform, auctioneer or
auction monitor
a. Name Marechale Capital
plc
b. LEI 2138003NUK6SXCDIAT89
4 Details of the
transaction(s): section to be
repeated for (i) each type of
instrument; (ii) each type of
transaction; (iii) each date;
and (iv) each place where
transactions have been
conducted
a. Description of the financial Grant of Options
instrument, type of over Ordinary Shares
instrument ISIN: GB0005401087
Identification Code
b. Nature of the transaction Grant of options
over ordinary shares
c) Price(s) and volume(s): Price(s) Volume(s)
per share
(p)
i. 4.75p i. 3,000,000
ii. 4.75p ii. 3,000,000
iii. 4.75p iii. 1,500,000
iv. 4.75p iv. 750,000
d. Aggregated information 8,250,000
· Volume
· Price 4.75p
e. Date of the transaction 10/07/2026
f. Place of the transaction Outside a trading
venue
This information was brought to you by Cision http://news.cision.com